Stock Market

CLSA maintains sell on Biocon, target price Rs 220

The company’s third quarter result was operationally in line with estimates but a higher tax rate led to a 10% miss on reported profit.

from Markets-Economic Times https://ift.tt/3aOASGi

No comments

Powered by Blogger.